We are live on ! Find out more
BPCE

Bank Pictet & Cie (Europe) Portfolio holdings

AUM $5.12B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+10.1%
1 Year Est. Return
+27.39%
3 Year Est. Return
+99.4%
5 Year Est. Return
+123.97%
10 Year Est. Return
+508.14%
AUM
$2.95B
AUM Growth
+$539M
Cap. Flow
+$312M
Cap. Flow %
10.58%
Top 10 Hldgs %
39.46%
Holding
286
New
114
Increased
66
Reduced
49
Closed
19

Top Buys

Rank Stock Value
1
EL icon
Estee Lauder
EL
+$35.2M
2
PDD icon
Pinduoduo
PDD
+$22.3M
3
PLD icon
Prologis
PLD
+$16.8M
4
CRM icon
Salesforce
CRM
+$13M
5
UNH icon
UnitedHealth
UNH
+$11.8M

Top Sells

Rank Stock Value
1
CCJ icon
Cameco
CCJ
+$29.2M
2
INTU icon
Intuit
INTU
+$11.5M
3
TMO icon
Thermo Fisher Scientific
TMO
+$10.8M
4
ALGN icon
Align Technology
ALGN
+$7.26M
5
SLB icon
SLB Ltd
SLB
+$5.51M

Sector Composition

Rank Sector Weight
1 Healthcare 21.46%
2 Technology 18.04%
3 Consumer Discretionary 13.98%
4 Communication Services 10.81%
5 Financials 10.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IWD icon
276
iShares Russell 1000 Value ETF
IWD
$84B
-33,875
Closed -$5.16M
NOBL icon
277
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.9B
-17,354
Closed -$792K
NTR icon
278
Nutrien
NTR
$32.1B
-20,160
Closed -$1.49M
PODD icon
279
Insulet
PODD
$10.1B
-958
Closed -$306K
RGEN icon
280
Repligen
RGEN
$9.35B
-2,210
Closed -$372K
RIO icon
281
Rio Tinto
RIO
$165B
-3,000
Closed -$206K
TNDM icon
282
Tandem Diabetes Care
TNDM
$1.63B
-6,377
Closed -$259K
UBS icon
283
UBS Group
UBS
$177B
-11,666
Closed -$246K
VWO icon
284
Vanguard FTSE Emerging Markets ETF
VWO
$126B
-19,189
Closed -$775K
CTLT
285
DELISTED
CATALENT, INC.
CTLT
-4,179
Closed -$275K
SGEN
286
DELISTED
Seagen Inc. Common Stock
SGEN
-1,900
Closed -$385K

Similar funds

Bank Pictet & Cie (Europe)'s Q2 2023 Portfolio in Review

As of Q2 2023, Bank Pictet & Cie (Europe) held 286 positions worth $2.95B, up 22% from $2.41B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Bank Pictet & Cie (Europe) deployed $312M of net new capital in Q2 2023, opening 114 new positions and adding to 66 existing holdings. Its largest new stake was Pinduoduo: 324,000 shares worth $22.4M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 25% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $10.8M trimmed.

  • Bank Pictet & Cie (Europe)'s largest Q2 2023 buy was Pinduoduo: 324,000 shares worth $22.4M.
  • Bank Pictet & Cie (Europe) added most to Estee Lauder in Q2 2023, an estimated $35.2M increase.
  • Bank Pictet & Cie (Europe)'s biggest Q2 2023 reduction was Thermo Fisher Scientific, cutting an estimated $10.8M.
  • Bank Pictet & Cie (Europe) fully exited Cameco in Q2 2023, selling an estimated $29.2M.
  • Bank Pictet & Cie (Europe)'s ten largest holdings make up 39% of its $2.95B portfolio in Q2 2023.
  • Bank Pictet & Cie (Europe) opened 114 new positions and closed 19 in Q2 2023.
  • Bank Pictet & Cie (Europe)'s portfolio value rose 22% quarter-over-quarter to $2.95B.

Based on Bank Pictet & Cie (Europe)'s 13F filing for Q2 2023, filed 8 Aug 2023.